Positive results in Phase 2 trial of treatment of C. difficile-associated diarrhoea
Monday, November 3, 2008 - 11:56
in Health & Medicine
Medarex, Inc. and The Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) today announced that a Phase 2 trial of an anti-C. difficile antibody combination treatment in patients with C. difficile Associated Diarrhoea (CDAD) successfully met its primary objective...